BSE Live
Dec 05, 16:01Prev. Close
1818.60
Open Price
1815.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
1818.30
Open Price
1819.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1805.30 (24)
| Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | |
| Total Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | |
| Reserves and Surplus | 45,024.52 | 41,169.13 | 37,860.63 | 36,399.74 | 32,741.82 | |
| Total Reserves and Surplus | 45,024.52 | 41,169.13 | 37,860.63 | 36,399.74 | 32,741.82 | |
| Total Shareholders Funds | 45,264.45 | 41,409.06 | 38,100.56 | 36,639.67 | 32,982.48 | |
| Minority Interest | 3,860.24 | 3,313.54 | 3,884.16 | 3,790.86 | 4,085.25 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 2,028.92 | 1,522.61 | 1,772.09 | 1,436.08 | 3,110.30 | |
| Deferred Tax Liabilities [Net] | 58.14 | 104.28 | 218.96 | 314.79 | 102.77 | |
| Other Long Term Liabilities | 823.28 | 574.31 | 58.25 | 130.71 | 209.65 | |
| Long Term Provisions | 511.00 | 430.39 | 404.46 | 1,211.11 | 1,895.86 | |
| Total Non-Current Liabilities | 3,421.34 | 2,631.59 | 2,453.76 | 3,092.69 | 5,318.58 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 5,549.38 | 8,370.76 | 7,979.70 | 6,654.92 | 5,206.12 | |
| Trade Payables | 3,583.64 | 4,147.87 | 4,766.20 | 4,395.39 | 3,582.92 | |
| Other Current Liabilities | 2,737.05 | 1,888.66 | 2,008.76 | 2,820.80 | 1,381.48 | |
| Short Term Provisions | 3,836.36 | 2,932.33 | 5,109.66 | 4,015.91 | 2,973.44 | |
| Total Current Liabilities | 15,706.43 | 17,339.62 | 19,864.32 | 17,887.02 | 13,143.96 | |
| Total Capital And Liabilities | 68,252.46 | 64,693.81 | 64,302.80 | 61,410.24 | 55,530.27 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 10,567.43 | 10,027.42 | 9,159.03 | 8,495.29 | 7,583.14 | |
| Intangible Assets | 5,798.02 | 5,853.35 | 4,086.91 | 3,643.66 | 2,654.37 | |
| Capital Work-In-Progress | 658.91 | 910.79 | 1,434.47 | 1,564.76 | 1,203.46 | |
| Fixed Assets | 17,585.79 | 17,291.92 | 15,711.10 | 14,940.33 | 12,412.96 | |
| Non-Current Investments | 5,245.75 | 3,951.81 | 3,052.25 | 961.00 | 1,116.07 | |
| Deferred Tax Assets [Net] | 3,175.29 | 2,554.87 | 2,193.78 | 2,492.82 | 3,148.99 | |
| Long Term Loans And Advances | 0.79 | 17.04 | 2,242.47 | 69.81 | 107.32 | |
| Other Non-Current Assets | 4,109.22 | 3,853.21 | 3,860.59 | 4,456.41 | 3,168.89 | |
| Total Non-Current Assets | 36,598.30 | 33,624.62 | 32,666.90 | 28,456.59 | 25,588.97 | |
| CURRENT ASSETS | ||||||
| Current Investments | 4,897.36 | 3,950.72 | 4,090.62 | 230.88 | 713.81 | |
| Inventories | 7,874.99 | 7,885.98 | 6,880.69 | 6,832.81 | 6,422.54 | |
| Trade Receivables | 9,421.24 | 8,884.20 | 7,815.28 | 7,202.61 | 6,775.66 | |
| Cash And Cash Equivalents | 6,487.55 | 7,275.60 | 9,929.38 | 15,140.84 | 13,181.65 | |
| Short Term Loans And Advances | 148.38 | 309.35 | 91.43 | 1,019.08 | 1,071.55 | |
| OtherCurrentAssets | 2,824.64 | 2,763.34 | 2,828.50 | 2,527.43 | 1,776.09 | |
| Total Current Assets | 31,654.16 | 31,069.19 | 31,635.90 | 32,953.65 | 29,941.30 | |
| Total Assets | 68,252.46 | 64,693.81 | 64,302.80 | 61,410.24 | 55,530.27 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 7,508.95 | 9,316.47 | 9,388.43 | 7,954.48 | 0.00 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 183.81 | 183.81 | 183.81 | 183.81 | 184.37 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 4,281.38 | 2,971.17 | 2,219.43 | 367.34 | 684.68 | |
| Non-Current Investments Unquoted Book Value | 834.29 | 849.34 | 642.95 | 200.32 | 174.84 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 4,493.68 | 3,388.60 | 3,572.67 | 23.01 | 23.68 | |
| Current Investments Unquoted Book Value | 403.68 | 562.12 | 517.95 | 207.87 | 690.13 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend